Judge Easterbrook sees through “feeble” antitrust claims raised by Sears shareholders
A three-judge panel for the 7th Circuit threw out a derivative suit brought by two Sears shareholders. They claim that two Sears directors, William C. Crowley and Ann N. Reese, also sit on other boards of competing businesses in violation of §8 of the Clayton Act. The district court in February 2010 did not dismiss the lawsuit, allowing §8 to be enforced by a private shareholder derivative suit.
The 7th Circuit, in an opinion written by Judge Easterbrook, joined by Judges Posner and Bauer, reversed the district court’s judgment, finding “this litigation is so feeble that it is best to end it immediately.” Judge Easterbrook noted that the shareholders did not make a demand on the board before bringing its lawsuit. Moreover, the antitrust-injury doctrine requires plaintiffs to have suffered harm from anticompetitive conduct. Shareholders would instead gain from collusion. “The problem is not only that perpetrators of antitrust offenses lack standing to complain about their own misconduct (which inures to their profit),” Easterbrook writes, “but also that, when such people do invoke the antitrust laws, likely they have other objectives in view.”
The opinion reserves sharp words for what it perceived to be these “other objectives”:
It is an abuse of the legal system to cram unnecessary litigation down the throats of firms whose directors serve on multiple boards, and then use the high costs of antitrust suits to extort settlements (including undeserved attorneys’ fees) from the targets.
Full content: WSJ Law Blog
Related content: Assessing Antitrust Injury in the Class Certification Context (William Rooney & Kristin McNamara, Willkie Farr)
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas